• EN

    • -+ 0.00%
    -+ 0.00%
    -+ 0.00%

    Is TPB’s Modern Oral Upgrade And Steady Dividend Altering The Investment Case For Turning Point Brands?

    Simply Wall St·05/17/2026 00:30:32
    Listen to the news
    • In early May 2026, Turning Point Brands reported first-quarter sales of US$124.28 million, up from US$106.44 million a year earlier, while net income fell to US$11.67 million and diluted earnings per share from continuing operations declined to US$0.60.
    • Alongside these results, the company raised its full-year 2026 Modern Oral gross and net sales guidance and affirmed a regular quarterly dividend of US$0.08 per share, highlighting the growing importance of Modern Oral products to its overall business mix.
    • Next, we’ll examine how the upgraded Modern Oral sales outlook interacts with Turning Point Brands’ pre-existing investment narrative and risk profile.

    Outshine the giants: these 16 early-stage AI stocks could fund your retirement.

    Turning Point Brands Investment Narrative Recap

    To own Turning Point Brands, you need to believe that Modern Oral can become the company’s primary growth engine without eroding profitability too much in the process. The latest results show stronger sales but softer earnings, which slightly clouds the short term catalyst of scaling Modern Oral profitably while underscoring the key risk that heavier investment and competition could pressure margins.

    The most relevant development is the sharply higher 2026 Modern Oral sales guidance, lifting expected gross sales to US$280 million to US$300 million and net sales to US$210 million to US$225 million. This reinforces how central Modern Oral is to the investment story, while also magnifying exposure to regulatory and competitive risks tied to that category.

    Yet investors should be aware that heavier spending to chase Modern Oral growth could still...

    Read the full narrative on Turning Point Brands (it's free!)

    Turning Point Brands' narrative projects $636.7 million revenue and $72.1 million earnings by 2029. This requires 11.2% yearly revenue growth and a $13.9 million earnings increase from $58.2 million today.

    Uncover how Turning Point Brands' forecasts yield a $132.50 fair value, a 48% upside to its current price.

    Exploring Other Perspectives

    TPB 1-Year Stock Price Chart
    TPB 1-Year Stock Price Chart

    Four members of the Simply Wall St Community currently see fair value for Turning Point Brands anywhere between about US$40 and US$159 per share, highlighting sharply different expectations. When you set those views against the company’s rising dependence on Modern Oral nicotine pouches, it underscores how crucial it is to weigh both growth potential and the risk of regulatory or competitive pressure before forming your own opinion.

    Explore 4 other fair value estimates on Turning Point Brands - why the stock might be worth less than half the current price!

    The Verdict Is Yours

    Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

    Seeking Other Investments?

    Our daily scans reveal stocks with breakout potential. Don't miss this chance:

    This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.